{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T05:15:06Z","timestamp":1720415706239},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,10]]},"DOI":"10.7759\/cureus.10353","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T10:49:10Z","timestamp":1599734950000},"source":"Crossref","is-referenced-by-count":1,"title":["Chronic Lymphoproliferative Disorder of Natural Killer Cells: A Rare Event"],"prefix":"10.7759","author":[{"given":"Shafain","family":"Sheikh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehreen","family":"Jahangir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samreen","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6890-5-8","article-title":"Persistence of natural killer (NK) cell lymphocytosis with hyposplenism without development of leukaemia","volume":"5","author":"Khan S","year":"2005","unstructured":"Khan S, Myers K. Persistence of natural killer (NK) cell lymphocytosis with hyposplenism without development of leukaemia. BMC Clin Pathol. 2005, 5:10.1186\/1472-6890-5-8","journal-title":"BMC Clin Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.b.21529","article-title":"The utility of flow cytometry in differentiating NK\/T cell lymphoma from indolent and reactive NK cell proliferations","volume":"94","author":"de Mel S","year":"2018","unstructured":"de Mel S, Li JB, Abid MB, et al.. The utility of flow cytometry in differentiating NK\/T cell lymphoma from indolent and reactive NK cell proliferations. Cytometry B Clin Cytom. 2018, 94:159-68. 10.1002\/cyto.b.21529","journal-title":"Cytometry B Clin Cytom"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23316","article-title":"Natural killer cell neoplasms","volume":"112","author":"Liang X","year":"2008","unstructured":"Liang X, Graham DK. Natural killer cell neoplasms. Cancer. 2008, 112:1425-36. 10.1002\/cncr.23316","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu369","article-title":"Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients","volume":"25","author":"Poullot E","year":"2014","unstructured":"Poullot E, Zambello R, Leblanc F, et al.. Chronic natural killer lymphoproliferative disorders: characteristics of an international cohort of 70 patients. Ann Oncol. 2014, 25:2030-35. 10.1093\/annonc\/mdu369","journal-title":"Ann Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.304","article-title":"Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets","volume":"24","author":"Morice WG","year":"2010","unstructured":"Morice WG, Jevremovic D, Olteanu H, et al.. Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsets. Leukemia. 2010, 24:881-4. 10.1038\/leu.2009.304","journal-title":"Leukemia"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-019-02625-x","article-title":"STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells","volume":"109","author":"Kawakami T","year":"2019","unstructured":"Kawakami T, Sekiguchi N, Kobayashi J, et al.. STAT3 mutations in natural killer cells are associated with cytopenia in patients with chronic lymphoproliferative disorder of natural killer cells. Int J Hematol. 2019, 109:563-71. 10.1007\/s12185-019-02625-x","journal-title":"Int J Hematol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-233403","article-title":"Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab","volume":"114","author":"Chee CE","year":"2009","unstructured":"Chee CE, Warrington KJ, Tefferi A. Chronic natural killer-cell lymphocytosis successfully treated with alemtuzumab. Blood. 2009, 114:3500-02. 10.1182\/blood-2009-07-233403","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/37854-chronic-lymphoproliferative-disorder-of-natural-killer-cells-a-rare-event","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:25:34Z","timestamp":1707506734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/37854-chronic-lymphoproliferative-disorder-of-natural-killer-cells-a-rare-event"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.10353","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,10]]}}}